The war on drugs that wasn’t: Wasted whiteness,“dirty doctors,” and race in media coverage of prescription opioid misuse J Netherland, HB Hansen Culture, Medicine, and Psychiatry 40, 664-686, 2016 | 430 | 2016 |
White opioids: Pharmaceutical race and the war on drugs that wasn’t J Netherland, H Hansen BioSocieties 12, 217-238, 2017 | 298 | 2017 |
Is the prescription opioid epidemic a white problem? H Hansen, J Netherland American journal of public health 106 (12), 2127-2129, 2016 | 213 | 2016 |
AIDS-related risk among adolescent males who have sex with males, females, or both: Evidence from a statewide survey C Goodenow, J Netherland, L Szalacha American journal of public health 92 (2), 203-210, 2002 | 207 | 2002 |
Factors affecting willingness to provide buprenorphine treatment J Netherland, M Botsko, JE Egan, AJ Saxon, CO Cunningham, ... Journal of substance abuse treatment 36 (3), 244-251, 2009 | 195 | 2009 |
Integration of buprenorphine/naloxone treatment into HIV clinical care: lessons from the BHIVES collaborative L Weiss, J Netherland, JE Egan, TP Flanigan, DA Fiellin, R Finkelstein, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 56, S68-S75, 2011 | 83 | 2011 |
The Physician Clinical Support System-Buprenorphine (PCSS-B): a novel project to expand/improve buprenorphine treatment JE Egan, P Casadonte, T Gartenmann, J Martin, EF McCance-Katz, ... Journal of general internal medicine 25, 936-941, 2010 | 76 | 2010 |
“Getting turned on”: using ICT training to promote active ageing in New York city PJ Gardner, T Kamber, J Netherland The journal of community informatics 8 (1), 2012 | 50 | 2012 |
The BHIVES collaborative: organization and evaluation of a multisite demonstration of integrated buprenorphine/naloxone and HIV treatment L Weiss, JE Egan, M Botsko, J Netherland, DA Fiellin, R Finkelstein JAIDS Journal of Acquired Immune Deficiency Syndromes 56, S7-S13, 2011 | 48 | 2011 |
How the war on drugs impacts social determinants of health beyond the criminal legal system A Cohen, SP Vakharia, J Netherland, K Frederique Annals of medicine 54 (1), 2024-2038, 2022 | 44 | 2022 |
Toward and age-friendly New York City: A findings report R Finkelstein, A Garcia, J Netherland The New York Academy of Medicine, 2018 | 43 | 2018 |
Roundtable on urban living environment research (RULER) D Vlahov, SR Agarwal, RM Buckley, WT Caiaffa, CF Corvalan, AC Ezeh, ... Journal of Urban Health 88, 793-857, 2011 | 43 | 2011 |
“We haven't Sliced Open anyone's Brain yet”: Neuroscience, Embodiment and the Governance of Addiction J Netherland Sociological reflections on the neurosciences, 153-177, 2011 | 42 | 2011 |
A vulnerable population in a time of crisis: drug users and the attacks on the World Trade Center L Weiss, A Fabri, K McCoy, P Coffin, J Netherland, R Finkelstein Journal of Urban Health 79, 392-403, 2002 | 39 | 2002 |
Patient perspectives on buprenorphine/naloxone treatment in the context of HIV care JE Egan, J Netherland, J Gass, R Finkelstein, L Weiss, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 56, S46-S53, 2011 | 38 | 2011 |
Race as a ghost variable in (white) opioid research H Hansen, C Parker, J Netherland Science, Technology, & Human Values 45 (5), 848-876, 2020 | 36 | 2020 |
Introduction: Sociology and the shifting landscape of addiction J Netherland Critical perspectives on addiction 14, xi-xxv, 2012 | 33 | 2012 |
White women, US popular culture, and narratives of addiction J Daniels, JC Netherland, AP Lyons Contemporary Drug Problems 45 (3), 329-346, 2018 | 27 | 2018 |
Whiteout: How racial capitalism changed the color of opioids in America H Hansen, J Netherland, D Herzberg Univ of California Press, 2023 | 24 | 2023 |
The cost of integrated HIV care and buprenorphine/naloxone treatment: results of a cross-site evaluation BR Schackman, JA Leff, M Botsko, DA Fiellin, FL Altice, PT Korthuis, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 56, S76-S82, 2011 | 24 | 2011 |